Usability of a Breathing-CBT Platform (CBT = Cognitive Behavioural Therapy)
Breathing and CBT Platform Usability Take-home Study
1 other identifier
interventional
10
1 country
1
Brief Summary
The study will examine the usability of a breathing platform in the home environment. It will be a randomized, open-label crossover study of 10 participants who will complete the CBT and breathing components in their home, prior to sleeping. Usability will be measured by scores assigned by participants. Qualitative feedback and compliance information will also be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2018
CompletedFirst Submitted
Initial submission to the registry
April 6, 2020
CompletedFirst Posted
Study publicly available on registry
March 1, 2021
CompletedMarch 1, 2021
February 1, 2021
29 days
April 6, 2020
February 25, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Ease of use
Participants will complete a questionnaire rating how easy it was to use and sleep with the device providing assistance to their breathing patterns
8 days
Secondary Outcomes (1)
Compliance
8 days
Study Arms (2)
Control with no device
ACTIVE COMPARATORBreathing performed with no device
Therapy - device assisted breathing
EXPERIMENTALBreathing performed with device
Interventions
Eligibility Criteria
You may qualify if:
- Participants are willing to give written, informed consent
- Participants are healthy adults
- Participants are able to comprehend and speak English
- Participants are at least 18 years of age
You may not qualify if:
- Participants who are/may be pregnant or lactating
- Participant that have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ResMedlead
Study Sites (1)
ResMed Ltd
Sydney, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeff Armitstead
ResMed
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2020
First Posted
March 1, 2021
Study Start
June 1, 2018
Primary Completion
June 30, 2018
Study Completion
July 30, 2018
Last Updated
March 1, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share